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Background
2G12 is a high affinity broadly neutralizing monoclonal
antibody against a high-mannose glycan cluster on gp120.
Its key feature is domain-exchanged heavy chains. Here,
we explored the minimal requirements for domain-
exchange. Although 2G12 is heavily mutated, only a
minority of mutations may be required for domain-
exchange.
Methods
Germline 2G12 was derived from the original nucleotide
sequence using IMGT/V-QUEST. Germline 2G12 was
cloned from genomic DNA and increasing numbers of
substitutions corresponding to the wild type 2G12
sequence were introduced in the heavy chain at specific
positions, expressed as an IgG in FS293 cells and purified
using affinity chromatography. Domain-exchange was
assessed by size exclusion chromatography of Fabs pre-
pared by papain digest.
Results
Germline 2G12 showed neither detectable binding to
gp120, nor was the antibody domain-exchanged. If only
the light chain was reverted to germline, the antibody
retained binding to gp120 and domain-exchange, but not
in the heavy chain only chimera.
Increasing numbers of wild type residues, beginning with
residues thought to promote domain-exchange (Calarese,
Science, 2003, 300: 2065), followed by residues crucial
for binding and rare residues in turns, lead to a signifi-
cantly domain-exchanged antibody.
None of the germline mutants tested detectably bound
gp120 or glycans on a standard glycan array.
Conclusion
Affinity maturation of germline 2G12 to a domain-
exchanged antibody requires multiple residues, including
framework residues away from the elbow region or H/H'-
interface, and is not obligatorily associated with binding
to gp120. Further studies will pinpoint the exact require-
ments for domain-exchange and may provide clues as to
how exchange may be promoted through immunization.
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